焦虑与非酒精性脂肪性肝病的关系

余荻; 杨旭瑶; 赵锦涵; 钏莉雪; 常江

doi:10.3969/j.issn.1001-5256.2020.11.043

焦虑与非酒精性脂肪性肝病的关系

DOI: 10.3969/j.issn.1001-5256.2020.11.043

昆明医科大学第二附属医院消化内科

详细信息

中图分类号: R575.5
计量
- 文章访问数: 692
- HTML全文浏览量: 66
- PDF下载量: 95
- 被引次数: 0
出版历程
- 收稿日期: 2020-04-19
- 出版日期: 2020-11-20

Association between anxiety and nonalcoholic fatty liver disease

Department of Gastroenterology,The Second Affiliated Hospital of Kunming Medical University

摘要

摘要:
近年来,随着生活方式的迅速改变,非酒精性脂肪性肝病（NAFLD）的患病率逐年递增并逐渐成为慢性肝病的主要病因之一。因生物-心理-社会医学模式的发展,心理疾病对躯体疾病的影响开始受到学者的关注。目前,研究显示焦虑作为最常见的精神障碍之一,其可能与NAFLD的发生发展有关。介绍了焦虑与NAFLD的研究现况以及双方共有的影响因素,并对焦虑致NAFLD的可能病理生理机制进行推测,期望为两者联系的进一步研究奠定基础,并为NAFLD的治疗提出新的方向。
- 非酒精性脂肪性肝病 /
- 焦虑 /
- 睡眠 /
- 胃肠道微生物组
Abstract:
With the rapid change in lifestyle in recent years,the prevalence rate of nonalcoholic fatty liver disease( NAFLD) is increasing year by year and it has gradually become one of the major causes of chronic liver diseases. With the development of the bio-psycho-social medical model,the influence of psychological diseases on physical diseases has attracted the attention of scholars. At present,evidence has shown that anxiety,as one of the most common type of mental disorders,may be associated with the development of NAFLD. This article introduces the current status of research on anxiety and NAFLD and their common influencing factors and predicts the possible pathophysiological mechanism of NAFLD caused by anxiety,so as to lay a foundation for further research on the association between anxiety and NAFLD and provide new directions for the treatment of NAFLD.
- non-alcoholic fatty liver disease /
- anxiety /
- sleep /
- gastrointestinal microbiome

HTML全文

参考文献(40)

[1] LI J,ZOU B,YEO YH,et al.Prevalence,incidence,and outcome of non-alcoholic fatty liver disease in Asia,1999-2019:A systematic review and meta-analysis[J].Lancet Gastroenterol Hepatol,2019,4(5):389-398.

[2]ZHOU F,ZHOU J,WANG W,et al.Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018:A systematic review and meta-analysis[J].Hepatology,2019,70(4):1119-1133.

[3]TAO YT,PAN Q,CHEN GY,et al.Survey of character and emotion condition of non-alcoholic fatty liver disease[J].J Pract Hepatol,2017,20(6):713-719.(in Chinese)陶叶婷,潘勤,陈光榆,等.非酒精性脂肪性肝病患者性格及情绪状态调查[J].实用肝脏病杂志,2017,20(6):713-719.

[4]ELWING JE,LUSTMAN PJ,WANG HL,et al.Depression,anxiety,and nonalcoholic steatohepatitis[J].Psychosom Med,2006,68(4):563-569.

[5]YOUSSEF NA,ABDELMALEK MF,BINKS M,et al.Associations of depression,anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease[J].Liver Int,2013,33(7):1062-1070.

[6]LIU YZ,CHEN JK,ZHANG Y,et al.Chronic stress induces steatohepatitis while decreases visceral fat mass in mice[J].BMC Gastroenterol,2014,14:106.

[7]CORONA-PEREZ A,DIAZ-MUNOZ M,CUEVAS-ROMERO E,et al.Interactive effects of chronic stress and a highsucrose diet on nonalcoholic fatty liver in young adult male rats[J].Stress,2017,20(6):608-617.

[8]KO YH,WONG TC,HSU YY,et al.The correlation between body fat,visceral fat,and nonalcoholic fatty liver disease[J].Metab Syndr Relat Disord,2017,15(6):304-311.

[9]JIANG B,CHEN Y,ZHOU K,et al.Comparison of abdominal obesity and fatty liver and their association with insulin resistance and metabolic syndrome in Chinese adults[J].Obesity(Silver Spring),2019,27(5):707-715.

[10]AMIRI S,BEHNEZHAD S.Obesity and anxiety symptoms:A systematic review and meta-analysis[J].Neuropsychiatr,2019,33(2):72-89.

[11]SWEENEY P,O'HARA K,XU Z,et al.HFD-induced energy states-dependent bidirectional control of anxiety levels in mice[J].Int J Obes(Lond),2017,41(8):1237-1245.

[12]ALONSO-CARABALLO Y,HODGSON KJ,MORGAN SA,et al.Enhanced anxiety-like behavior emerges with weight gain in male and female obesity-susceptible rats[J].Behav Brain Res,2019,360:81-93.

[13]CAPURON L,POITOU C,MACHAUX-THOLLIEZ D,et al.Relationship between adiposity,emotional status and eating behaviour in obese women:Role of inflammation[J].Psychol Med,2011,41(7):1517-1528.

[14]SOTO M,HERZOG C,PACHECO JA,et al.Gut microbiota modulate neurobehavior through changes in brain insulin sen-sitivity and metabolism[J].Mol Psychiatry,2018,23(12):2287-2301.

[15]FOURRIER C,BOSCH-BOUJU C,BOURSEREAU R,et al.Brain tumor necrosis factor-αmediates anxiety-like behavior in a mouse model of severe obesity[J].Brain Behav Immun,2019,77:25-36.

[16]LIU J,GUO M,ZHANG D,et al.Adiponectin is critical in determining susceptibility to depressive behaviors and has antidepressant-like activity[J].Proc Natl Acad Sci U S A,2012,109(30):12248-12253.

[17]GUO M,LI C,LEI Y,et al. Role of the adipose PPAR_γ-adiponectin axis in susceptibility to stress and depression/anxiety-related behaviors[J].Mol Psychiatry,2017,22(7):1056-1068.

[18]GARIBALLA S,ALKAABI J,YASIN J,et al.Total adiponectin in overweight and obese subjects and its response to visceral fat loss[J].BMC Endocr Disord,2019,19(1):55.

[19]REN SM,MEl L,HUANG H,et al. Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease[J].Chin J Hepatol,2019,27(5):369-375.(in Chinese)任士萌,梅璐,黄煌,等.非酒精性脂肪性肝病患者肠道菌群及生物化学指标相关性分析[J].中华肝脏病杂志,2019,27(5):369-375.

[20]SOBHONSLIDSUK A,CHANPRASERTYOTHIN S,PONGRUJIKORN T,et al.The association of gut microbiota with nonalcoholic steatohepatitis in Thais[J].Biomed Res Int,2018,2018:9340316.

[21] YAMADA S,KAMADA N,AMIYA T,et al.Gut microbiotamediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitis[J].BMC Gastroenterol,2017,17(1):136.

[22]MATSUSHITA N,OSAKA T,HARUTA I,et al.Effect of lipopolysaccharide on the progression of non-alcoholic fatty liver disease in high caloric diet-fed mice[J].Scand J Immunol,2016,83(2):109-118.

[23]MAHANA D,TRENT CM,KURTZ ZD,et al.Antibiotic perturbation of the murine gut microbiome enhances the adiposity,insulin resistance,and liver disease associated with high-fat diet[J].Genome Med,2016,8(1):48.

[24]JIANG HY,ZHANG X,YU ZH,et al.Altered gut microbiota profile in patients with generalized anxiety disorder[J].J Psychiatr Res,2018,104:130-136.

[25]JANG HM,LEE KE,LEE HJ,et al.Immobilization stress-induced Escherichia coli causes anxiety by inducing NF-κB activation through gut microbiota disturbance[J].Sci Rep,2018,8(1):13897.

[26]FIELDS CT,CHASSAING B,CASTILLO-RUIZ A,et al.Effects of gut-derived endotoxin on anxiety-like and repetitive behaviors in male and female mice[J].Biol Sex Differ,2018,9(1):7.

[27]LUO Y,ZENG B,ZENG L,et al.Gut microbiota regulates mouse behaviors through glucocorticoid receptor pathway genes in the hippocampus[J].Transl Psychiatry,2018,8(1):187.

[28]LAURIOLA M,CARLETON RN,TEMPESTA D,et al.A correlational analysis of the relationships among intolerance of uncertainty,anxiety sensitivity,subjective sleep quality,and insomnia symptoms[J].Int J Environ Res Public Health,2019,16(18):3253.

[29]ZHAI K,GAO X,WANG G.The role of sleep quality in the psychological well-being of final year undergraduatestudents in China[J].Int J Environ Res Public Health,2018,15(12).

[30]WATANABE JH,CHAU DL.Anxiety and depression symptoms and every-night sleep medication use in older adults[J].Sr Care Pharm,2019,34(7):449-455.

[31]ZHANG K,LI YJ,FENG D,et al.Imbalance between TNFαand progranulin contributes to memory impairment and anxiety in sleep-deprived mice[J].Sci Rep,2017,7:43594.

[32]HARKNESS JH,BUSHANA PN,TODD RP,et al.Sleep disruption elevates oxidative stress in parvalbumin-positive cells of the rat cerebral cortex[J].Sleep,2019,42(1):zsy201.

[33]WIJARNPREECHA K,THONGPRAYOON C,PANJAWATANAN P,et al.Insomnia and risk of nonalcoholic fatty liver disease:A systematic review and meta-analysis[J].J Postgrad Med,2017,63(4):226-231.

[34]OKAMURA T,HASHIMOTO Y,HAMAGUCHI M,et al.Short sleep duration is a risk of incident nonalcoholic fatty liver disease:A population-based longitudinal study[J].J Gastrointestin Liver Dis,2019,28(1):73-81.

[35]MARIN-ALEJANDRE BA,ABETE I,CANTERO I,et al.Association between sleep disturbances and liver status in obese subjects with nonalcoholic fatty liver disease:A comparison with healthy controls[J].Nutrients,2019,11(2):322.

[36]SAYIN FK,BUYUKINAN M.Sleep duration and media time have a major impact on insulin resistance and metabolic risk factors in obese children and adolescents[J].Child Obes,2016,12(4):272-278.

[37]BUXTON OM,PAVLOVA M,REID EW,et al.Sleep restriction for 1 week reduces insulin sensitivity in healthy men[J].Diabetes,2010,59(9):2126-2133.

[38]LIU C,ZHONG R,LOU J,et al.Nighttime sleep duration and risk of nonalcoholic fatty liver disease:The Dongfeng-Tongji prospective study[J].Ann Med,2016,48(6):468-476.

[39]BERNSMEIER C,WEISSKOPF DM,PFLUEGER MO,et al.Sleep disruption and daytime sleepiness correlating with disease severity and insulin resistance in non-alcoholic fatty liver disease:A comparison with healthy controls[J].PLoS One,2015,10(11):e0143293.

[40]QU H,WANG H,DENG M,et al.Associations between longer habitual day napping and non-alcoholic fatty liver disease in an elderly Chinese population[J]. PLoS One,2014,9(8):e105583.

施引文献

资源附件(0)

访问统计